Vytelle doubles its bovine IVF lab capacity; outpacing goals since its $13.2M round

December 1, 2022  |  Startland News Staff

Kerryann Kocher, Vytelle

A five-year plan initiated by Vytelle’s Series A funding round called for the agtech startup to double its laboratory capacity to produce bovine embryos through in vitro fertilization. Just a year later, the Lenexa-headquarted company already has opened its fifth new lab.

Vytelle’s Franklin, Tennessee, laboratory; photo courtesy of Vytelle

Vytelle’s latest facility — in Franklin, Tennessee — is accessible to beef and dairy seedstock producers through on-farm ovum pick-ups and satellite locations, the startup detailed, noting previously opened labs in Albany, New York; Fort Worth, Texas; and Gainesville, Florida; in addition to Hamilton, New Zealand.

Click here to learn more about Vytelle’s $13.2 oversubscribed round in 2021, which included backing from Kansas City venture capital firm KCRise Fund.

“Vytelle is the fastest growing bovine IVF company in the world,” said Kerryann Kocher, CEO of Vytelle. “Producers are accelerating genetic progress — replicating their elite animals with hormone-free IVF. This last lab places Vytelle within reach of 50 percent of the US breeding stock, making hormone-free technology more accessible to our customers.”

RELATED: KC capital implants cattle tech startup with fuel to scale, expanding IVF labs, headcount

Vytelle is an integrated technology platform built to accelerate genetic progress in cattle; photo courtesy of Vytelle

Vytelle’s platform combines Vytelle ADVANCE, a breakthrough IVF technology, with Vytelle SENSE, an animal performance data capture system, and Vytelle INSIGHT, an artificial intelligence-based genetic analytics engine. 

The platform provides progressive cattle producers the technology to make reliable data-driven mating decisions that improve the predictability of genetic progress replicating the right genetics faster.

Producers are able to access Vytelle’s bovine hormone-free IVF process by bringing donors to any of the more than 30 satellite locations across the United States or by scheduling an on-farm ovum pick-up.

Click here to learn more about Vytelle, an integrated technology platform built to accelerate genetic progress in cattle.

This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that works together with communities in education and entrepreneurship to create uncommon solutions and empower people to shape their futures and be successful.

For more information, visit www.kauffman.org and connect at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn

startland-tip-jar

TIP JAR

Did you enjoy this post? Show your support by becoming a member or buying us a coffee.

Tagged , ,
Featured Business
    Featured Founder

      2022 Startups to Watch

        stats here

        Related Posts on Startland News

        Events Preview: Athena League, investor pitch

        By Tommy Felts | July 23, 2015

        There are a boatload of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious Kansas Citian, we’d recommend these upcoming events for you. WEEKLY EVENT PREVIEW Don’t miss out tonight Athena League July VOX When: July 23 @ 5:30 pm – 7:30 pm Where: Village Square Coworking Studio…

        Sharing economy hits agriculture with FarmLink service

        By Tommy Felts | July 23, 2015

        A new-age economic model is entering the world’s oldest industry. Kansas City-based FarmLink introduced this week its Web-based farm equipment sharing community MachineryLink Sharing, which the company says will enable farmers to save money and generate revenue. “Agriculture is in the midst of its next big transformation, where new thinking and business models that have revolutionized…

        Metactive lands $224K for nonclinical studies

        By Tommy Felts | July 22, 2015

        Olathe-based Metactive Medical recently secured a grant that will continue the development of its embolization device that fights cancer. The National Institutes of Health awarded Metactive $224,000 that will fund nonclinical studies on the performance of the company’s Blockstent Microcatheter embolic devices for the occlusion — or blockage — of peripheral arteries and veins. “We believe…

        Mighty Handle grips massive market with Walmart deal

        By Tommy Felts | July 22, 2015

        A Kansas City startup recently grabbed a retail deal that will put its product in front of millions of customers. Mighty Handle last week signed a deal with Walmart stores that will roll out its product to help users carry multiple shopping bags at about 3,500 stores nationwide. So what’s it mean for Mighty Handle…